Wang Laboratories Inc has other things on its mind just now, but the other shoe has dropped, and Moody’s Investors Service Inc has followed Standard & Poor’s Corp in cutting its rating on Wang’s $410m of convertible subordinated debt – to Ca from Caa in the wake of the company’s Chapter 11 filing.
